Established and Emerging Roles of Biomarkers in Heart Failure.
Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost, morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis, prognostication, and management of patients with HF and are incorporated into HF clinical practice guidelines. Beyond the natriuretic peptides, novel biomarkers may supplement traditional clinical and laboratory testing to improve understanding of the complex disease process of HF and possibly to personalize care for those affected through better individual phenotyping. In this review, we will discuss natriuretic peptides and the more novel biomarkers by dividing them into categories based on the major pathophysiologic pathways they represent. Given the complex physiology in HF, it is reasonable to expect that the future of biomarker testing lies in the application of multimarker testing panels, precision medicine to improve HF care delivery, and the use of biomarkers in proteomics and metabolomics to further improve HF care.
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Renin-Angiotensin System
- Oxidative Stress
- Humans
- Heart Failure
- Evaluation Studies as Topic
- Cardiovascular System & Hematology
- Biomarkers
- Apoptosis
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Renin-Angiotensin System
- Oxidative Stress
- Humans
- Heart Failure
- Evaluation Studies as Topic
- Cardiovascular System & Hematology
- Biomarkers
- Apoptosis
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology